Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kira O'Neil Bona, M.D.

Co-Author

This page shows the publications co-authored by Kira Bona and Joanne Wolfe.
Connection Strength

4.264
  1. Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). Pediatr Blood Cancer. 2016 Jun; 63(6):1012-8.
    View in: PubMed
    Score: 0.671
  2. Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study. Pediatr Blood Cancer. 2016 Jan; 63(1):105-11.
    View in: PubMed
    Score: 0.652
  3. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015 Feb; 21(2):312-8.
    View in: PubMed
    Score: 0.612
  4. Economic impact of advanced pediatric cancer on families. J Pain Symptom Manage. 2014 Mar; 47(3):594-603.
    View in: PubMed
    Score: 0.560
  5. Naming the Problem: A Structural Racism Framework to Examine Disparities in Palliative Care. J Pain Symptom Manage. 2021 Aug 13.
    View in: PubMed
    Score: 0.245
  6. Race, ethnicity, and goal-concordance of end-of-life palliative care in pediatric oncology. Cancer. 2021 Oct 15; 127(20):3893-3900.
    View in: PubMed
    Score: 0.244
  7. PediCARE: Development of a poverty-targeted intervention for pediatric cancer. Pediatr Blood Cancer. 2021 Oct; 68(10):e29195.
    View in: PubMed
    Score: 0.243
  8. The relationship between household income and patient-reported symptom distress and quality of life in children with advanced cancer: A report from the PediQUEST study. Cancer. 2018 10 01; 124(19):3934-3941.
    View in: PubMed
    Score: 0.200
  9. Feasibility of systematic poverty screening in a pediatric oncology referral center. Pediatr Blood Cancer. 2018 12; 65(12):e27380.
    View in: PubMed
    Score: 0.199
  10. Household material hardship in families of children post-chemotherapy. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.187
  11. Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. J Clin Oncol. 2011 Mar 10; 29(8):1007-13.
    View in: PubMed
    Score: 0.118
  12. Pediatric Palliative Care Parents' Distress, Financial Difficulty, and Child Symptoms. J Pain Symptom Manage. 2021 Aug 20.
    View in: PubMed
    Score: 0.061
  13. Pediatric Palliative Care in the Multicultural Context: Findings From a Workshop Conference. J Pain Symptom Manage. 2019 04; 57(4):846-855.e2.
    View in: PubMed
    Score: 0.051
  14. Hope, distress, and later quality of life among adolescent and young adults with cancer. J Psychosoc Oncol. 2018 Mar-Apr; 36(2):137-144.
    View in: PubMed
    Score: 0.047
  15. The Benefits and Burdens of Cancer: A Prospective Longitudinal Cohort Study of Adolescents and Young Adults. J Palliat Med. 2017 05; 20(5):494-501.
    View in: PubMed
    Score: 0.045
  16. Intimacy, Substance Use, and Communication Needs During Cancer Therapy: A Report From the "Resilience in Adolescents and Young Adults" Study. J Adolesc Health. 2017 01; 60(1):93-99.
    View in: PubMed
    Score: 0.044
  17. The benefits and burdens of cancer: A prospective, longitudinal cohort study of adolescents and young adults. J Clin Oncol. 2016 Oct 09; 34(26_suppl):243.
    View in: PubMed
    Score: 0.044
  18. Adolescent and Young Adult Patient Engagement and Participation in Survey-Based Research: A Report From the "Resilience in Adolescents and Young Adults With Cancer" Study. Pediatr Blood Cancer. 2016 Apr; 63(4):734-6.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.